Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Lionmesh Prima Tbk. (LMSH) vs Organon Pharma Indonesia Tbk. (SCPI)

Lionmesh Prima Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Lionmesh Prima Tbk. dan Organon Pharma Indonesia Tbk.: Lionmesh Prima Tbk. diperdagangkan di Rp256 (kapitalisasi pasar 24,58 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. jauh lebih besar — sekitar 4,2× kapitalisasi pasar Lionmesh Prima Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

LMSHSCPI
Kapitalisasi Pasar
24,58 M104,4 M

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LMSH
Lihat detail
SCPI
Lihat detail

Tentang Lionmesh Prima Tbk.

PT Lionmesh Prima Tbk (the Company) was originally under the name PT Lion Weldmesh Prima and established on December 14, 1982. The Company its started commercial operations in 1984.

Selengkapnya di halaman LMSH

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI